Apex Cardiology, LLC
Jackson, Tennessee, United States
Medical clinic in Jackson, Tennessee
327 Summar Dr, Jackson, TN 38301
About Apex Cardiology, LLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Abbott Medical Devices
1
Boehringer Ingelheim
1
Novartis Pharmaceuticals
1
Pfizer
1
Clinical Trials at Apex Cardiology, LLC
During the past decade, Apex Cardiology, LLC conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
St. Jude Medical Product Longevity and Performance (SCORE) Registry
2007-11-01
2020-07-10
Completed
10,957
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
2014-10-28
2017-07-10
Completed
746
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016
Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
2021-11-23
2027-10-13
Recruiting
15,000
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
2022-12-05
2025-08-25
Recruiting
18,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Apex Cardiology, LLC" #1 sponsor was "Bayer" with 2 trials, followed by "Abbott Medical Devices" with 1 trials
sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Apex Cardiology, LLC"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Apex Cardiology, LLC
According to Clinical.Site data, the most researched conditions in "Apex Cardiology, LLC" are
"Heart Failure" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials), "Bradycardia" (1 trials) and "Heart Disease" (1 trials). Many other conditions were trialed in "Apex Cardiology, LLC" in a lesser frequency.
Clinical Trials Intervention Types at Apex Cardiology, LLC
Most popular intervention types in "Apex Cardiology, LLC" are "Drug" (5 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Apex Cardiology, LLC
The vast majority of trials in "Apex Cardiology, LLC" are
6 trials for "All" genders.
Clinical Trials Status at Apex Cardiology, LLC
Currently, there are NaN active trials in "Apex Cardiology, LLC".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Apex Cardiology, LLC,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Apex Cardiology, LLC, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".